Diffusion Pharmaceuticals Inc. (44)
Browse by Contract Category
Contracts
-
Agreement, dated as of December 15, 2022, by and among Diffusion Pharmaceuticals Inc, LifeSci Special Opportunities Master Fund Ltd., LifeSci Special Opportunities Partners L.P.,...
(Filed With SEC on December 16, 2022)
-
Employment Agreement, effective May 18, 2022, by and between the Company and Raven Jaeger, M.S
(Filed With SEC on June 28, 2022)
-
Form of Subscription Agreement between Diffusion Pharmaceuticals Inc. and the investors named therein, dated March 18, 2022
(Filed With SEC on March 18, 2022)
-
Engagement Letter, dated March 27, 2020, by and between the Company and H.C. Wainwright & Co. LLC
(Filed With SEC on May 20, 2020)
-
At-The-Market Sales Agreement, dated July 22, 2022, by and between Diffusion Pharmaceuticals Inc. and BTIG, LLC
(Filed With SEC on July 22, 2022)
-
Form of Director RSU Agreement under 2015 Equity Incentive Plan
(Filed With SEC on March 18, 2022)
-
Form of Stock Option Award Agreement under 2015 Equity Incentive Plan
(Filed With SEC on March 18, 2022)
-
Amended & Restated Underwriting Agreement, dated February 11, 2021, by and between Diffusion Pharmaceuticals Inc. and H.C. Wainwright & Co., LLC
(Filed With SEC on February 18, 2021)
-
Form of Underwriter Warrant
(Filed With SEC on February 18, 2021)
-
Employment Agreement, dated as of October 19, 2020, by and between Diffusion Pharmaceuticals Inc. and Christopher D. Galloway
(Filed With SEC on October 20, 2020)
-
Employment Agreement, dated as of September 23, 2020, by and between Diffusion Pharmaceuticals Inc. and William R. Elder
(Filed With SEC on September 25, 2020)
-
Separation Agreement, dated as of September 8, 2020, by and between Diffusion Pharmaceuticals Inc. and David G. Kalergis
(Filed With SEC on September 9, 2020)
-
Employment Agreement, dated as of September 8, 2020, by and between Diffusion Pharmaceuticals Inc. and Robert J. Cobuzzi, Ph.D
(Filed With SEC on September 9, 2020)
-
Form of Securities Purchase Agreement, dated May 18, 2020, by and among the Company and the purchasers party thereto
(Filed With SEC on May 20, 2020)
-
Form of Warrant
(Filed With SEC on May 20, 2020)
-
Form of Placement Agent Warrant issued on May 8, 2020
(Filed With SEC on May 8, 2020)
-
Form of New Warrant issued on May 8, 2020
(Filed With SEC on May 8, 2020)
-
Warrant Exercise Agreement, dated May 6, 2020, by and between Diffusion Pharmaceuticals Inc. and the purchaser thereto
(Filed With SEC on May 8, 2020)
-
Consulting Agreement, dated March 12, 2020, by and between Diffusion Pharmaceuticals Inc. and John L. Gainer
(Filed With SEC on March 18, 2020)
-
Separation Agreement, dated March 12, 2020, by and between Diffusion Pharmaceuticals Inc. and John L. Gainer
(Filed With SEC on March 18, 2020)
-
Description of Securities
(Filed With SEC on March 17, 2020)
-
Engagement Letter, dated December 11, 2019, between the Company and H.C. Wainwright & Co., LLC
(Filed With SEC on December 13, 2019)
-
Form of Securities Purchase Agreement, dated December 11, 2019, by and among the Company and the purchasers party thereto
(Filed With SEC on December 13, 2019)
-
Form of Placement Agent Warrant
(Filed With SEC on December 13, 2019)
-
Form of Warrant
(Filed With SEC on December 13, 2019)
-
Form of Series I Warrant
(Filed With SEC on November 13, 2019)
-
Form of Series II Warrant
(Filed With SEC on November 13, 2019)
-
Form of Wainwright Warrant
(Filed With SEC on November 13, 2019)
-
Securities Purchase Agreement
(Filed With SEC on November 13, 2019)
-
Form of Pre-Funded Warrant
(Filed With SEC on November 13, 2019)
-
Form of Securities Purchase Agreement
(Filed With SEC on November 8, 2019)
-
Engagement Letter, dated October 7, 2019, by and between Diffusion Pharmaceuticals Inc. and H.C. Wainwright & Co., LLC
(Filed With SEC on November 8, 2019)
-
Form of Placement Agents Warrant
(Filed With SEC on November 8, 2019)
-
Form of Underwriters Warrant
(Filed With SEC on November 8, 2019)
-
Form of Pre-Funded Warrant
(Filed With SEC on November 8, 2019)
-
Form of Common Warrant
(Filed With SEC on November 8, 2019)
-
Form of Underwriters Warrant
(Filed With SEC on October 28, 2019)
-
Form of Pre-Funded Warrant
(Filed With SEC on October 28, 2019)
-
Form of Common Warrant
(Filed With SEC on October 28, 2019)
-
Form of Underwriting Agreement, dated [_______], by and between the Company and H.C. Wainwright & Co., LLC
(Filed With SEC on October 28, 2019)
-
Form of Placement Agent Warrant
(Filed With SEC on May 28, 2019)
-
Engagement Letter, dated May 3, 2019, between the Company and H.C. Wainwright & Co., LLC
(Filed With SEC on May 28, 2019)
-
Form of Securities Purchase Agreement, dated May 23, 2019, by and among the Company and the purchasers party thereto
(Filed With SEC on May 28, 2019)
-
Form of Warrant
(Filed With SEC on May 28, 2019)